Heptapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-11-01 and is reviewed periodically as new material appears.
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
| Property | Value | Notes |
|---|---|---|
| Solubility | Freely soluble in water | Also in aqueous buffers |
| Typical purity (HPLC) | 95 percent or higher | Lot-dependent |
| Dry powder storage | Minus 20 degrees Celsius | Sealed, dry, protected from light |
| Solution storage | 2 to 8 degrees Celsius | Short-term use |
| Identity confirmation | Mass spectrometry | ESI or MALDI-TOF |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.
Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.
Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Deprotonation of the ring-OH group converts kojic acid to kojate. Kojate chelates to iron(III), forming a red complex Fe(HOCH2C5OH2O2)3. This kind of reaction may be the basis of the biological function of kojic acid, that is, to solubilize ferric iron. Being a multifunctional molecule, kojic acid has diverse organic chemistry. The hydroxymethyl group gives the chloromethyl derivative upon treatment with thionyl chloride. Zinc-reduction of the chloromethyl compound gives allomaltol.
Diacetyl (or 2,3-butanedione) is the compound associated with the "buttery" aromas of Chardonnays, but it can affect any wine that has gone through malolactic fermentation. At an odor detection threshold of 0.2 mg/L in white wines and 2.8 mg/L in red wines, it can be perceived as slightly buttery or "nutty" while at concentrations greater than 5 to 7 mg/L (5-7 ppm) can overwhelm other aroma notes in the wine. Diacetyl can be produced by the LAB through metabolism of sugar or of citric acid. While citric acid is naturally present in grapes, it is in a very small amount with most of it coming from deliberate addition by the winemaker to acidify the wine. In the presence of both malic and citric acids, the LAB use both, but use the malic much more quickly, with the rate of citric use/diacetyl formation influenced by the particular bacterial strain (with most strains of O. oeni producing less diacetyl than Lactobacillus and Pediococcis species), as well as the redox potential of the wine. In wine conditions that have a low redox potential (meaning it is more oxidative such as in a barrel that is not fully topped up), more citric acid will be consumed and diacetyl formed. In more reductive conditions, such as in alcoholic fermentations where yeast populations are at their peak and the wine is heavily saturated with carbon dioxide, the formation of diacetyl is much slower. The yeasts also help keep levels low by consuming diacetyl and reducing it to acetoin and butylene glycol.
=== FTIR as detector in chromatography === The speed of FTIR allows spectra to be obtained from compounds as they are separated by a gas chromatograph. However this technique is little used compared to GC-MS (gas chromatography-mass spectrometry) which is more sensitive. The GC-IR method is particularly useful for identifying isomers, which by their nature have identical masses. Liquid chromatography fractions are more difficult because of the solvent present. One notable exception is to measure chain branching as a function of molecular size in polyethylene using gel permeation chromatography, which is possible using chlorinated solvents that have no absorption in the area in question.
Sources: en.wikipedia.org
AHCC is widely used in the world and many people use it for general health maintenance and treatment of various diseases. It is often used as a complementary and alternative medicine (CAM) for immune support, as reports in animal and clinical settings have indicated that AHCC is associated with an enhanced response to infection and increased survival. AHCC is in some cases also used by those undergoing conventional cancer therapy (e.g. chemotherapy) for its reported immunomodulatory functions. In Japan, AHCC is the 2nd most popular complementary and alternative medicine used by cancer patients. Agaricus blazei supplements are the most popular, outpacing AHCC use by a factor of 7:1.
99Tc, half-life 211 ka, is produced at a yield of about 6% per fission; see also the main fission products page. It is also produced (via the short-lived nuclear isomer technetium-99m) as a decay product of molybdenum-99. Technetium is particularly mobile in the environment as it forms negatively charged pertechnetate-ions (TcO−4, resembling the permanganate anion), and it presents the biggest radiological hazard among the long-lived fission products. Despite being a metal, technetium usually does not form positively charged ions, but technetium halides like technetium hexafluoride exist. TcF6 is a nuisance in uranium enrichment as its boiling point (328.4 K (55.3 °C; 131.4 °F)) is very close to that of uranium hexafluoride (329.6 K (56.5 °C; 133.6 °F)). The issue is known to enrichment facilities because spontaneous fission also yields small amounts of technetium (which will be in secular equilibrium with its parent nuclides in natural uranium) but if fluoride volatility is employed for reprocessing, a significant share of the "uranium" separated by fractional distillation will be contaminated with technetium requiring a further purification step. Technetium-99 is suitable for nuclear transmutation by slow neutrons as it has a sufficient thermal neutron cross section and as it has no known stable isotopes. Under neutron irradiation, Tc-99 forms Tc-100 which quickly decays to stable 100Ru a valuable platinum group metal.
An international study, using modelling and literature assessment, codifies, integrates into and quantifies "safe and just Earth system boundaries" (ESBs) with the context of Earth system stability and minimization of human harm. They expand upon earlier boundary frameworks by incorporating concepts such as intra- and intergenerational justice, propose that their framework may better enable a quantitative foundation for safeguarding the global commons, and report many of the ESBs are already exceeded. Healthcare systems related results are published: large increases in medication prices via sustained decrease in their use can cause poorer disease control (8 May), widespread implementation of the particular Alzheimer's disease therapeutic solution lecanemab may increase annual U.S. Medicare spending by $2.0 to $5.1 billion (11 May), mailed HPV self-collection kits with scheduling assistance can lead to greater uptake of cervical cancer screening (11 May), cost-related medication nonadherence occurs in approximately 1 in 5 older adults in the U.S. in 2022 (18 May), and a QALY-based health economics study evaluates the cost-effectiveness of U.S. population-wide screening for CKD (23 May).
Sources: en.wikipedia.org
Reverse-phase HPLC is the usual method and gives a percentage purity value. Mass spectrometry then confirms the molecular mass. Together they provide a basic identity and purity profile for a lot.
Freeze-dried material is kept frozen, often at minus 20 degrees Celsius, and protected from light and moisture. Dissolved peptide is refrigerated for short-term use. Repeated freeze-thaw cycles are avoided.
A certificate of analysis typically lists purity by HPLC, the confirmed mass, appearance, and sometimes water or counter-ion content. It documents results for a specific batch. Details vary by supplier.
Selank is a synthetic heptapeptide designed as a stabilized analog of the natural tetrapeptide tuftsin. It has been investigated mainly for anxiolytic and cognitive effects. It is not an approved pharmaceutical in most countries.